Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Czarina N Behrends

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Urban Health : Bulletin of the New York Academy of Medicine|January 17, 2025
Expanded Naloxone Distribution by Opioid Overdose Prevention Programs to High-Need Populations and Neighborhoods in New York CityCzarina N Behrends, Andrew J Trinidad, Michelle L Nolan, et al.
JAMA Network Open|November 9, 2022
Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode IslandXiao Zang, Sam E Bessey, Maxwell S Krieger, et al.
JAMA Network Open|May 30, 2024
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid SettlementXiao Zang, Alexandra Skinner, Maxwell S Krieger, et al.
Addiction (Abingdon, England)|November 26, 2021
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode IslandShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
Substance Use & Misuse|January 15, 2025
"New Normal:" Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 PandemicElizabeth J Austin, Elsa S Briggs, Maria A Corcorran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2020
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US CitiesXiao Zang, Emanuel Krebs, Siyuan Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2019
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US CitiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
AIDS (London, England)|December 4, 2019
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States citiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
The Lancet. HIV|March 9, 2020
Ending the HIV epidemic in the USA: an economic modelling study in six citiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
AIDS (London, England)|June 21, 2021
Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US citiesEmanuel Krebs, Eva Enns, Xiao Zang, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Urban Health : Bulletin of the New York Academy of Medicine|January 17, 2025
Expanded Naloxone Distribution by Opioid Overdose Prevention Programs to High-Need Populations and Neighborhoods in New York CityCzarina N Behrends, Andrew J Trinidad, Michelle L Nolan, et al.
JAMA Network Open|November 9, 2022
Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode IslandXiao Zang, Sam E Bessey, Maxwell S Krieger, et al.
JAMA Network Open|May 30, 2024
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid SettlementXiao Zang, Alexandra Skinner, Maxwell S Krieger, et al.
Addiction (Abingdon, England)|November 26, 2021
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode IslandShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
Substance Use & Misuse|January 15, 2025
"New Normal:" Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 PandemicElizabeth J Austin, Elsa S Briggs, Maria A Corcorran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2020
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US CitiesXiao Zang, Emanuel Krebs, Siyuan Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2019
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US CitiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
AIDS (London, England)|December 4, 2019
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States citiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
The Lancet. HIV|March 9, 2020
Ending the HIV epidemic in the USA: an economic modelling study in six citiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
AIDS (London, England)|June 21, 2021
Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US citiesEmanuel Krebs, Eva Enns, Xiao Zang, et al.
Pageof 5